Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future

Cardiovascular disease (CVD), despite the advances of the medical field, remains one of the leading causes of mortality worldwide. Discovering novel treatments based on cell therapy or drugs is critical, and induced pluripotent stem cells (iPS Cells) technology has made it possible to design extensi...

Full description

Bibliographic Details
Main Authors: Marianna Tsifaki, Sophia Kelaini, Rachel Caines, Chunbo Yang, Andriana Margariti
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-08-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fcvm.2018.00109/full
id doaj-2fcd02ea972d448f9883f88ee7f870eb
record_format Article
spelling doaj-2fcd02ea972d448f9883f88ee7f870eb2020-11-25T00:19:55ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2018-08-01510.3389/fcvm.2018.00109403990Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the FutureMarianna TsifakiSophia KelainiRachel CainesChunbo YangAndriana MargaritiCardiovascular disease (CVD), despite the advances of the medical field, remains one of the leading causes of mortality worldwide. Discovering novel treatments based on cell therapy or drugs is critical, and induced pluripotent stem cells (iPS Cells) technology has made it possible to design extensive disease-specific in vitro models. Elucidating the differentiation process challenged our previous knowledge of cell plasticity and capabilities and allows the concept of cell reprogramming technology to be established, which has inspired the creation of both in vitro and in vivo techniques. Patient-specific cell lines provide the opportunity of studying their pathophysiology in vitro, which can lead to novel drug development. At the same time, in vivo models have been designed where in situ transdifferentiation of cell populations into cardiomyocytes or endothelial cells (ECs) give hope toward effective cell therapies. Unfortunately, the efficiency as well as the concerns about the safety of all these methods make it exceedingly difficult to pass to the clinical trial phase. It is our opinion that creating an ex vivo model out of patient-specific cells will be one of the most important goals in the future to help surpass all these hindrances. Thus, in this review we aim to present the current state of research in reprogramming toward the cardiovascular system's regeneration, and showcase how the development and study of a multicellular 3D ex vivo model will improve our fighting chances.https://www.frontiersin.org/article/10.3389/fcvm.2018.00109/fullreprogrammingvascular cellsregenerationcardiovascular systeminduced pluripotent stem cells (iPS Cells)
collection DOAJ
language English
format Article
sources DOAJ
author Marianna Tsifaki
Sophia Kelaini
Rachel Caines
Chunbo Yang
Andriana Margariti
spellingShingle Marianna Tsifaki
Sophia Kelaini
Rachel Caines
Chunbo Yang
Andriana Margariti
Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future
Frontiers in Cardiovascular Medicine
reprogramming
vascular cells
regeneration
cardiovascular system
induced pluripotent stem cells (iPS Cells)
author_facet Marianna Tsifaki
Sophia Kelaini
Rachel Caines
Chunbo Yang
Andriana Margariti
author_sort Marianna Tsifaki
title Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future
title_short Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future
title_full Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future
title_fullStr Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future
title_full_unstemmed Regenerating the Cardiovascular System Through Cell Reprogramming; Current Approaches and a Look Into the Future
title_sort regenerating the cardiovascular system through cell reprogramming; current approaches and a look into the future
publisher Frontiers Media S.A.
series Frontiers in Cardiovascular Medicine
issn 2297-055X
publishDate 2018-08-01
description Cardiovascular disease (CVD), despite the advances of the medical field, remains one of the leading causes of mortality worldwide. Discovering novel treatments based on cell therapy or drugs is critical, and induced pluripotent stem cells (iPS Cells) technology has made it possible to design extensive disease-specific in vitro models. Elucidating the differentiation process challenged our previous knowledge of cell plasticity and capabilities and allows the concept of cell reprogramming technology to be established, which has inspired the creation of both in vitro and in vivo techniques. Patient-specific cell lines provide the opportunity of studying their pathophysiology in vitro, which can lead to novel drug development. At the same time, in vivo models have been designed where in situ transdifferentiation of cell populations into cardiomyocytes or endothelial cells (ECs) give hope toward effective cell therapies. Unfortunately, the efficiency as well as the concerns about the safety of all these methods make it exceedingly difficult to pass to the clinical trial phase. It is our opinion that creating an ex vivo model out of patient-specific cells will be one of the most important goals in the future to help surpass all these hindrances. Thus, in this review we aim to present the current state of research in reprogramming toward the cardiovascular system's regeneration, and showcase how the development and study of a multicellular 3D ex vivo model will improve our fighting chances.
topic reprogramming
vascular cells
regeneration
cardiovascular system
induced pluripotent stem cells (iPS Cells)
url https://www.frontiersin.org/article/10.3389/fcvm.2018.00109/full
work_keys_str_mv AT mariannatsifaki regeneratingthecardiovascularsystemthroughcellreprogrammingcurrentapproachesandalookintothefuture
AT sophiakelaini regeneratingthecardiovascularsystemthroughcellreprogrammingcurrentapproachesandalookintothefuture
AT rachelcaines regeneratingthecardiovascularsystemthroughcellreprogrammingcurrentapproachesandalookintothefuture
AT chunboyang regeneratingthecardiovascularsystemthroughcellreprogrammingcurrentapproachesandalookintothefuture
AT andrianamargariti regeneratingthecardiovascularsystemthroughcellreprogrammingcurrentapproachesandalookintothefuture
_version_ 1725369771955847168